Journal article
Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
Curēus (Palo Alto, CA), v 10(12), 3775
24 Dec 2018
PMID: 30820394
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
This is a pilot study comparing the 30 and 60 day relapse rates for schizophrenic patients treated with long-acting injectable antipsychotics versus traditional oral antipsychotics in a community hospital setting. This is a retrospective cohort study and medical records were reviewed to gather data involving readmission rates. We analyzed the data using relative risk (RR) for the 30 days and 60 days after patient discharge from the behavioral health unit of a community hospital.
Metrics
10 Record Views
Details
- Title
- Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
- Creators
- Eduardo D. Espiridion - Calvert Memorial HospitalCallum Lewandrowski - Calvert Memorial HospitalShiva Shahriari - Calvert Memorial HospitalDorothy F. Bestoyong - Calvert Memorial Hospital
- Publication Details
- Curēus (Palo Alto, CA), v 10(12), 3775
- Publisher
- Springer Nature
- Number of pages
- 4
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Psychiatry
- Web of Science ID
- WOS:000461069500074
- Other Identifier
- 991021889834304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Psychiatry